Costes intangibles de la dependencia alcohólica desde la perspectiva de los pacientes y sus familiares: un estudio de valoración contingente

Jacinto Mosquera Nogueira, Eva Rodríguez-Míguez

Resumen


La dependencia alcohólica produce múltiples problemas no sólo a la persona que la padece sino también a su entorno. En este estudio se utiliza la valoración contingente para valorar los efectos intangibles de la dependencia alcohólica, desde la perspectiva de las personas directamente implicadas: pacientes y familiares. Se ha entrevistado a 145 pacientes y 61 familiares. Los efectos intangibles de la dependencia alcohólica se obtienen a partir de la disponibilidad a pagar por un hipotético tratamiento para la dependencia, ante dos escenarios de éxito (50% y 100%). La disponibilidad a pagar media mensual de la población alcohólica es de 129€ y 168€, respectivamente, por los tratamientos con un 50% y un 100% de éxito. La disponibilidad de los familiares es mayor en ambos escenarios (307€ y 420€, respectivamente), lo cual podría ser explicado por su mayor percepción de los problemas familiares, laborales y de salud generados por la dependencia alcohólica. El análisis de regresión realizado muestra que la eficacia del tratamiento, la renta personal y tener un deterioro moderado de la salud influyen positivamente en la disponibilidad a pagar de los pacientes, e influye negativamente estar desanimado y deprimido. Los resultados de este estudio pueden ser aplicados a estudios de evaluación económica cuyo objetivo es medir los beneficios de programas destinados a reducir la prevalencia de la dependencia alcohólica. Los costes intangibles estimados pueden ser añadidos a los costes directos e indirectos habitualmente utilizados.

Palabras clave


Alcohol; Dependencia; Familia; Valoración contingente; Disposición a pagar

Texto completo:

PDF PDF (English)

Referencias


Amin, M. y Khondoker, F. (2004). A contingent valuation study to estimate the parental willingness-to-pay for childhood diarrhea and gender bias among rural households in India. Health Research Policy and Systems, 2, 1359-1386. doi:10.1186/1478-4505-2-3. 

Anderson, P. y Baumberg, B. (2006). Alcohol in Europe. London: Institute of Alcohol Studies. Recuperado de http://ec.europa.eu/health-eu/news_alcoholineurope_en.htm. 

Arrow, K., Solow, R., Portney, P. R., Leamer, E. E., Radner, R. y Schuman, H. (1993). Report of the NOAA Panel on Contingent Valuation. Federal Register 58, 4602–4614.

Baumberg, B. (2010). Best practice in estimating the costs of alcohol–Recommendations for future studies. WHO Regional Office for Europe. Recuperado de   http://www.euro.who.int/_data/assets/pdf_file/0009/112896/E93197.pdf . 

Bergmo, T. S. y Wangberg, S. C. (2007). Patients’ willingness to pay for electronic communication with their general practitioner. The European Journal of Health Economics, 8, 105-110. doi:10.1007/s10198-006-0014-5.

Bishai, D., Sindelar, J., Ricketts, E. P., Huettner, S., Cornelius, L., Lloyd, J. J., ... Strathdee, S. A. (2008). Willingness to pay for drug rehabilitation: implications for cost recovery. Journal of Health Economics, 27, 959-972. doi:10.1016/j.jhealeco.2007.11.007.

Blumenschein, K., Johannesson, M., Yokoyama, K. y Freeman, P. (2001). Hypothetical versus real willingness to pay in the health care sector: results from a field experiment. Value in Health, 4, 79-79. doi:10.1046/j.1524-4733.2001.40202-36.x. 

Boonen, A., Severens, J. L., Van Tubergen, A., Landewé, R., Bonsel, G., Van der Heijde, D. y van der Linden, S. (2005). Willingness of patients with ankylosing spondylitis to pay for inpatient treatment is influenced by the treatment environment and expectations of improvement. Annals of the Rheumatic Diseases, 64, 1650-1652. doi:10.1136/ard.2005.038786. 

Brazier, J., Akehurst, R., Brennan, A., Dolan, P., Claxton, K., McCabe, C., ... Tsuchyia, A. (2005). Should patients have a greater role in valuing health states?. Applied Health Economics and Health Policy, 4, 201-208. doi:10.2165/00148365-200504040-00002. 

Burling, T. A., Reilly, P. M., Moltzen, J. O. y Ziff, D. C. (1989). Self-efficacy and relapse among inpatient drug and alcohol abusers: a predictor of outcome. Journal of Studies on Alcohol, 50, 354-360. doi:10.15288/jsa.1989.50.354. 

Byrne, M. M., O’Malley, K. y Suarez-Almazor, M. E. (2005). Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis. Medical Decision Making, 25, 655-666. doi:10.1177/0272989X05282638. 

Carson, R. T. y Hanemann, W. M. (2005). Contingent Valuation. In K. G. Maler & J. R. Vincent (Eds.), the Handbook of Environmental Economics: Valuing Environmental Changes (Vol. 2), pp 821-920. Elsevier.

Chisholm, D., Rehm, J., Van Ommeren, M. y Monteiro, M. (2004). Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. Journal of Studies on Alcohol, 65, 782-793. doi:10.15288/jsa.2004.65.782. 

Collins, D. J. y Lapsley, H. M. (2008). The avoidable costs of alcohol abuse in Australia and the potential benefits of effective policies to reduce the social costs of alcohol (pp. 1-51). Australian Government Department of Health & Ageing. Recuperado de http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/content/mono70.

Corry, J., Sanderson, K., Issakidis, C., Andrews, G. y Lapsley, H. (2004). Evidence-based care for alcohol use disorders is affordable. Journal of Studies on Alcohol. 65, 521–529. doi:10.15288/jsa.2004.65.521. 

Diamond, P. A. y Hausman, J. A. (1994). Contingent valuation: Is some number better than no number?. The Journal of Economic Perspectives, 8, 45-64.doi:10.1257/jep.8.4.45. 

Donaldson, C., Thomas, R. y Torgerson, D. J. (1997). Validity of open-ended and payment scale approaches to eliciting willingness to pay. Applied Economics, 29, 79-84. doi:10.1080/000368497327425.  

Fautrel, B., Clarke, A. E., Guillemin, F., Adam, V., St-Pierre, Y., Panaritis, T., ... Penrod, J.  R. (2007). Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method. Medical Decision Making, 27, 138-150.   doi:10.1016/j.healthpol.2008.12.011. 

Fernández, A., Saameño, J. Á. B., Pinto-Meza, A., Luciano, J. V., Autonell, J., Palao, D., ... Serrano, A. (2010). Burden of chronic physical conditions and mental disorders in primary care. The British Journal of Psychiatry, 196, 302-309. doi:10.1192/bjp.bp.109.074211. 

Gabriel, S. E., Kneeland, T. S., Melton, L. J., Moncur, M. M., Ettinger, B. y Tosteson, A. N. (1999). Health-related Quality of Life in Economic Evaluations for Osteoporosis Whose Values Should We Use?. Medical Decision Making, 19, 141-148. doi:10.1007/s00198-008-0743-7.

García-Pérez, L., Aguiar-Ibáñez, R., Pinilla-Domínguez, P., Arvelo-Martín, A., Linertová, R. y Rivero-Santana, A. (2014). Revisión sistemática de utilidades relacionadas con la salud en España: el caso de la salud mental. Gaceta Sanitaria, 28, 77-83. 

Grandes, G., Montoya, I., Arietaleanizbeaskoa, M. S., Arce, V. y Sanchez, A. (2011). The burden of mental disorders in primary care. European Psychiatry, 26, 428-435. 

Greenberg, D., Bakhai, A., Neumann, P. J. y Cohen, D. J. (2004). Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study. Health Policy, 70, 207-216. doi:10.1016/j.healthpol.2004.03.002. 

Gueylard-Chenevier, D. G. y LeLorier, J. (2005). A willingness-to-pay assessment of parents’ preference for shorter duration treatment of acute otitis media in children. Pharmacoeconomics, 23, 1243-1255. doi:10.1186/1477-7525-8-75. 

Gyrd-Hansen, D., Jensen, M. L. y Kjaer, T. (2014). Framing the willingness-to-pay question: Impact on response patterns and mean willingness to pay. Health Economics, 23, 550-563. doi:10.1002/hec.2932. 

He, M., Chan, V., Baruwa, E., Gilbert, D., Frick, K. D. y Congdon, N. (2007). Willingness to pay for cataract surgery in rural Southern China. Ophthalmology 114, 411–416.         doi:10.1016/j.ophtha.2006.09.012. 

Jarl, J., Johansson, P., Eriksson, A., Eriksson, M., Gerdtham, U. G., Hemström, Ö., ... Room, R. (2008). The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002. The European Journal of Health Economics, 9, 351-360. doi:10.1007/S10198-007-0082-1 

Jeanrenaud, C. y Pellegrini, S. (2007). Valuing intangible costs of alcohol dependence: A contingent valuation study. Revue d’Economie Politique, 117, 813-825. doi:10.3917/redp.175.0813. 

Jimoh, A., Sofola, O., Petu, A. y Okorosobo, T. (2007). Quantifying the economic burden of malaria in Nigeria using the willingness to pay approach. Cost Effectiveness and Resource Allocation, 5, 1. doi:10.1186/1478-7547-5-6. 

Johansson, P., Jarl, J., Eriksson, A., Eriksson, M., Gerdtham, U. G., Hemström, Ö., ... Room, R. (2006). The social costs of alcohol in Sweden 2002. Stockholms Universitet, Centrum för socialvetenskaplig alkohol-och drogforskning (SoRAD). doi:10.1007/S10198-007-0082-1. 

John, U., Rumpf, H. J., Bischof, G., Hapke, U., Hanke, M. y Meyer, C. (2013). Excess Mortality of Alcohol-Dependent Individuals After 14 Years and Mortality Predictors Based on Treatment Participation and Severity of Alcohol Dependence. Alcoholism: Clinical and Experimental Research, 37, 156-163. doi:10.1111/j.1530-0277.2012.01863.x. 

Kraemer, K. L., Roberts, M. S., Horton, N. J., Palfai, T., Samet, J. H., Freedner, N., ... Saitz, R. (2005). Health utility ratings for a spectrum of alcohol-related health states. Medical Care, 43, 541-550. doi:10.1097/01.mlr.0000163644.97251.14. 

Laslett, A. M., Catalano, P., Chikritzhs, T., Dale, C., Doran, C., Ferris, J., ... Room, R. (2010). The range and magnitude of alcohol’s harm to others. AER Centre for Alcohol Policy Research, Turning Point Alcohol and Drug Centre, Eastern Health: Fitzroy, Victoria

Maheswaran, H., Petrou, S., Rees, K. y Stranges, S. (2013). Estimating EQ-5D utility values for major health behavioural risk factors in England. Journal of Epidemiology and Community Health, 67, 172-180. doi:10.1136/jech-2012-201019. 

Mann, R., Brazier, J. y Tsuchiya, A. (2009). A comparison of patient and general population weightings of EQ-5D dimensions. Health Economics, 18, 363-372. doi:10.1002/hec.1362. 

Mortimer, D. y Segal, L. (2005). Economic evaluation of interventions for problem drinking and alcohol dependence: cost per QALY estimates. Alcohol and Alcoholism, 40, 549-555. doi:10.1093/alcalc/agh192  

Mosquera J. y Rodríguez-Míguez, E. (2015). Using the SF-6D to measure the impact of alcohol dependence on health-related quality of life. The European Journal of Health Economics, 16, 347-356. doi:10.1007/s10198-014-0627-z.

Navarro, H. J., Doran, C. M. y Shakeshaft, A. P. (2011). Measuring costs of alcohol harm to others: A review of the literature. Drug and alcohol dependence, 114, 87-99.                doi:10.1016/j.drugalcdep.2010.11.009. 

Neumann, P. J. y Johannesson, M. (1994). The willingness to pay for in vitro fertilization: a pilot study using contingent valuation. Medical Care, 32, 686-699. doi:10.1186/1472-6963-8-261. 

Nutt, D. J., King, L. A. y Phillips, L. D. (2010). Drug harms in the UK: a multicriteria decision analysis. The Lancet, 376, 1558-1565. doi:10.1016/S0140-6736(10)61462-6. 

Parrott, S., Godfrey, C., Heather, N., Clark, J. y Ryan, T. (2006). Cost and outcome analysis of two alcohol detoxification services. Alcohol and Alcoholism, 4, 84-91 doi:10.1093/alcalc/agh236. 

Petersen, S., Peto, V., Rayner, M., Leal, J., Luengo-Fernández, R. y Gray, A. (2005). European cardiovascular disease statistics: 2005 edition. (pp 70-72). British Heart Foundation. Department of Public Health, University of Oxford. 

Petrie, D., Doran, C. y Shakeshaft, A. (2011). Willingness to pay to reduce alcohol-related harm in Australian rural communities. Expert Review of Pharmacoeconomics & Outcomes Research, 11, 351-363. doi:10.1586/erp.11.28.

Petrie, D., Doran, C., Shakeshaft, A. y Sanson-Fisher, R. (2008). The relationship between alcohol consumption and self-reported health status using the EQ5D: evidence from rural Australia. Social Science & Medicine, 67, 1717-1726. doi:10.1016/j.socscimed.2008.09.017 .

Pinto-Prades, J. L., Farreras, V. y de Bobadilla, J. F. (2008). Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone. The European Journal of Health Economics, 9, 69-78. doi:10.1007/sl0198-007-0041-x.

Rehm, J., Room, R., Monteiro, M., Gmel, G., Graham, K., Rehn, T.,... Jernigan, D. (2004). Comparative quantification of health risks: global and regional burden of disease due to selected major risk factors, World Health Organization. Retrieved at: www.who.int/publications/cra/chapters/volume1/0959-1108.pdf. 

Rehm, J., Rehm, M., Shield, K., Gmel, G. y Gual, T. (2013). Alcohol consumption, alcohol dependence and related harms in Spain, and the effect of treatment-based interventions on alcohol dependence. Adicciones, 25, 11-18.. doi:10.1186/1747-597X-8-21. 

Saarni, S. I., Suvisaari, J., Sintonen, H., Pirkola, S., Koskinen, S., Aromaa, A. y Lönnqwist, J. (2007). Impact of psychiatric disorders on health-related quality of life: general population survey. The British Journal of Psychiatry, 190, 326-332. doi:10.1016/j.comppsych.2008.06.003. 

Sadri, H., MacKeigan, L. D., Leiter, L. A. y Einarson, T. R. (2005). Willingness to pay for inhaled insulin. Pharmacoeconomics, 23, 1215-1227. doi:10.1016/j.sapharm.2008. 10.001. 

Sanderson, K., Andrews, G., Corry, J. y Lapsley, H. (2004). Using the effect size to model change in preference values from descriptive health status. Quality of Life Research, 13, 1255-1264. doi:10.1023/B:QURE.0000037482.92757.82. 

Smith, R. D. (2003). Construction of the contingent valuation market in health care: a critical assessment. Health Economics, 12, 609-628. doi:10.1002/hec.755. 

Stouthard, M. E., Essink-Bot, M. L. y Bonsel, G. L.  (2000). Disability weights for diseases: a modified protocol and results for a Western European region. The European Journal of Public Health, 10, 24-30. doi:10.1093/eurpub/10.1.24 24-30. 

Tang, C. H., Liu, J. T., Chang, C. W. y Chang, W. Y. (2007). Willingness to pay for drug abuse treatment: results from a contingent valuation study in Taiwan. Health Policy, 82, 251-262. doi:10.1016/j.healthpol.2006.09.007. 

Ubel, P. A., Loewenstein, G. y Jepson, C. (2003). Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Quality of Life Research, 12, 599-607. doi:10.1023/A:1025119931010. 

UKATT Research Team. (2005). Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). The British Medical Journal, 331, 544. doi:10.1093/alcalc/agn112. 

Unützer, J., Katon, W. J., Russo, J., Simon, G., Von Korff, M., Lin, E., ... Bush, T. (2003). Willingness to pay for depression treatment in primary care. Psychiatric Services, 54, 340–345. doi:10.1176/ps.54.3.340.

Viscusi, W. K., Magat, W. A. y Huber, J. (1987). An investigation of the rationality of consumer valuations of multiple health risks. The RAND Journal of Economics, 18, 465-479.

Walsh, B. M. y Bartfield, J. M. (2006). Survey of parental willingness to pay and willingness to stay for” painless” intravenous catheter placement. Pediatric Emergency Care, 22, 699-703. doi:10.1097/01.pec.0000238743.96606.69. 

Whynes, D. K., Frew, E. y Wolstenholme, J. L. (2003). A comparison of two methods for eliciting contingent valuations of colorectal cancer screening. Journal of Health Economics, 22, 555-574. doi:10.1016/S0167-6296(03)00006-7. 

Yasunaga, H., Ide, H., Imamura, T. y Ohe, K. (2006). Benefit evaluation of mass screening for prostate cancer: willingness-to-pay measurement using contingent valuation. Urology, 68, 1046-1050.  doi:10.1111/j.1442-2042.2009.02293.x. 

Zarkin, G. A., Cates, S. C. y Bala, M. V. (2000). Estimating the willingness to pay for drug abuse treatment: A pilot study. Journal of Substance Abuse Treatment, 18, 149-159.        doi:10.1016/S0740-5472(99)00030-6.




DOI: https://doi.org/10.20882/adicciones.851

Enlaces refback

  • No hay ningún enlace refback.